Related references
Note: Only part of the references are listed.Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima et al.
NATURE GENETICS (2017)
Molecular features of early onset adult myelodysplastic syndrome
Cassandra M. Hirsch et al.
HAEMATOLOGICA (2017)
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
Bon Ham Yip et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape
P. Silva et al.
LEUKEMIA (2017)
Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures
Jermaine L. Jenkins et al.
TRENDS IN GENETICS (2017)
Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome
Cara Lunn Shirai et al.
NATURE COMMUNICATIONS (2017)
Molecular features of early onset adult myelodysplastic syndrome
Cassandra M. Hirsch et al.
HAEMATOLOGICA (2017)
How do messenger RNA splicing alterations drive myelodysplasia?
Poorval Joshi et al.
BLOOD (2017)
Age-related mutations and chronic myelomonocytic leukemia
C. C. Mason et al.
LEUKEMIA (2016)
Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions
Ali N. Chamseddine et al.
CURRENT ONCOLOGY REPORTS (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis
Daichi Inoue et al.
GENES & DEVELOPMENT (2016)
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation
Matteo G. Della Porta et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3′ End Formation
Sung Mi Park et al.
MOLECULAR CELL (2016)
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge et al.
NATURE REVIEWS CANCER (2016)
Mechanisms and Regulation of Alternative Pre-mRNA Splicing
Yeon Lee et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Luca Malcovati et al.
BLOOD (2015)
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Cara Lunn Shirai et al.
CANCER CELL (2015)
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms
R. J. Molenaar et al.
LEUKEMIA (2015)
Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis
Thomas McKerrell et al.
CELL REPORTS (2015)
U2AF1 mutations alter splice site recognition in hematological malignancies
Janine O. Ilagan et al.
GENOME RESEARCH (2015)
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T. Haferlach et al.
LEUKEMIA (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Stem cell origin of myelodysplastic syndromes
H. K. Elias et al.
ONCOGENE (2014)
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
Shang-Ju Wu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Misregulation of Pre-mRNA Alternative Splicing in Cancer
Jian Zhang et al.
CANCER DISCOVERY (2013)
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol et al.
BLOOD (2012)
The Life History of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts
Rui Cui et al.
LEUKEMIA RESEARCH (2012)
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Timothy A. Graubert et al.
NATURE GENETICS (2012)
Cyclosporin A and thalidomide in patients with myelodysplastic syndromes: Results of a pilot study
Zhijian Xiao et al.
LEUKEMIA RESEARCH (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Low-dose melphalan in myelodysplastic syndromes: an effective treatment for elderly RAEB-I or II patients?
Zhijian Xiao et al.
LEUKEMIA & LYMPHOMA (2010)
Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries
B Chen et al.
LEUKEMIA (2005)
Share Paper
